As of 2024-12-15, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is
-0.03 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.01 CAD, the upside of Revive Therapeutics Ltd is
-771.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.03 CAD
Intrinsic Value
RVV.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.03 - -0.03 |
-0.03 |
-771.18% |
| P/E |
0.00 - 0.00 |
0.00 |
-6.0% |
| DDM - Stable |
(0.07) - (0.27) |
(0.17) |
-3445.9% |
| DDM - Multi |
(0.00) - (0.00) |
(0.00) |
-131.6% |
RVV.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4.19 |
| Beta |
4.51 |
| Outstanding shares (mil) |
837.13 |
| Enterprise Value (mil) |
3.44 |
| Market risk premium |
5.10% |
| Cost of Equity |
8.56% |
| Cost of Debt |
5.00% |
| WACC |
8.53% |